XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
TAXES ON INCOME
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
TAXES ON INCOME
NOTE 14: -
TAXES ON INCOME
 
  a.
Corporate tax rates:
 
The Israeli corporate income tax rate was 23% in 2023, 2022 and 2021.
 
  b.
Foreign Exchange Regulations:
 
Commencing in taxable year 2012, the Company has elected to measure its taxable income and file its tax return under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income) 1986 ("Foreign Exchange Regulations"). Under the Foreign Exchange Regulations, an Israeli company must calculate its tax liability in U.S. Dollars according to certain rules. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.
 
  c.
Pre-tax income (loss) is comprised as follows:
 
   
Year ended
December 31,
 
   
2023
   
2022
   
2021
 
                   
Domestic
 
$
(64,360
)
 
$
(32,826
)
 
$
(15,419
)
Foreign
   
2,640
     
2,691
     
2,230
 
                         
   
$
(61,720
)
 
$
(30,135
)
 
$
(13,189
)

 

  d.
A reconciliation of the theoretical tax expenses, assuming all income is taxed at the statutory tax rate applicable to the income of the Company and the actual tax expenses is as follows:
 
   
Year ended
December 31,
 
   
2023
   
2022
   
2021
 
                   
Loss before taxes on income
 
$
(61,720
)
 
$
(30,135
)
 
$
(13,189
)
                         
Theoretical tax income computed at the Israeli statutory tax rate (23% for the years 2023, 2022 and 2021, respectively)
 
$
(14,196
)
 
$
(6,931
)
 
$
(3,034
)
                         
Changes in valuation allowance
   
13,131
     
4,116
     
2,604
 
                         
Write off of prepaid and withholding taxes
   
749
     
1,388
     
875
 
Foreign tax rates differences related to subsidiaries
   
20
     
46
     
14
 
Non-deductible expenses and exempt income
   
(269
)
   
512
     
71
 
Capital note and inter-company balances release taxes
   
-
     
544
     
100
 
Other expenses and Exchange rate differences
   
(37

)

   
195
     
488
 
Non-deductible share-based compensation expense
   
1,586
     
1,925
     
633
 
Change in uncertain tax positions
   
100
     
100
     
100
 
                         
Actual tax expense
 
$
1,084
   
$
1,895
   
$
1,851
 

 

  e.
Taxes on income
 
Income tax expense is comprised as follows:
 
   
Year ended December 31,
 
   
2023
   
2022
   
2021
 
                   
Current taxes
 
$
248
   
$
391
   
$
334
 
Deferred taxes expense
   
-
     
-
     
420
 
Taxes in respect of previous years
   
(13
)
   
16
     
122
 
Write off of prepaid and withholding taxes
   
749
     
1,388
     
875
 
Change in expense associated with tax positions for current year
   
100
     
100
     
100
 
                         
   
$
1,084
   
$
1,895
   
$
1,851
 

 

Taxes on income by jurisdiction were as follows:
 
   
Year ended December 31,
 
   
2023
   
2022
   
2021
 
                   
Domestic
 
$
822
   
$
1,129
   
$
973
 
Foreign
   
262
     
766
     
878
 
                         
Total
 
$
1,084
   
$
1,895
   
$
1,851
 

 

Domestic
                 
Taxes in respect of previous years
 

$

-
 
 

$

(20
)
 

$

37
 
Write off of prepaid and withholding taxes
   
822
     
1,149
     
936
 
                         
Total Domestic
 
$
822
   
$
1,129
   
$
973
 
 
Foreign
                 
Current taxes
 
$
248
   
$
391
   
$
334
 
Deferred taxes expense
   
-
     
-
     
420
 
Taxes in respect of previous years
   
(13
)
   
36
     
85
 
Write off of prepaid and withholding taxes
   
(73
)
   
239
     
(61
)
Change in expense associated with tax positions for current year
   
100
     
100
     
100
 
                         
Total foreign
 
$
262
   
$
766
   
$
878
 
                         
Total income tax expense (benefit)
 
$
1,084
   
$
1,895
   
$
1,851
 
 
  f.
Net operating losses carry forward:
 
The Company has accumulated net operating losses for Israeli tax purposes as of December 31, 2023, in the amount of approximately $ 118,905, which may be carried forward and offset against taxable income in the future for an indefinite period. As of December 31, 2023, the Company recorded a full valuation allowance with respect to its net deferred tax assets in Allot Ltd. and wrote-off prepaid and withholding taxes of $ 6,297 as the Company does not expect to utilize these tax assets in the near future. In addition, the Company has accumulated capital losses for tax purposes as of December 31, 2023, of approximately $ 27,191, which may be carried forward and offset against taxable capital gains in the future for an indefinite period. Management currently believes that since the Company has a history of losses, and uncertainty with respect to future taxable income, it is more likely than not that the deferred tax assets regarding the loss carry forwards will not be utilized in the foreseeable future. Thus, a valuation allowance was provided to reduce deferred tax assets to their realizable value.
 
The U.S. subsidiary has accumulated losses for U.S. federal income tax return purposes of approximately $ 1,615 and $ 5,414 for state taxes. The federal accumulated losses for tax purposes expire between 2027 and 2038. As of December 31, 2023, the Company recorded a valuation allowance with respect to its deferred tax assets in the US Subsidiary.
 
A portion of the losses are subject to limitations of Internal Revenue Code, Section 382, which in general provides that utilization of net operating losses is subject to an annual limitation if an ownership change results from transactions increasing the ownership of certain shareholders or public groups in the share of a corporation by more than 50 percentage points over a three-year period. The annual limitations may result in the expiration of losses before utilization.
 
  g.
Deferred income taxes:
 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred income taxes are as follows:
 
   
December 31,
 
   
2023
   
2022
 
Deferred tax assets:
           
Operating and capital loss carryforwards
 
$
34,420
   
$
25,962
 
Research and development
   
8,423
     
10,260
 
Employee benefits
   
1,522
     
1,286
 
Intangible assets
   
353
     
77
 
Operating lease liabilities
   
496
     
1,178
 
Stock based compensation expenses
   
1,733
     
1,481
 
Onerous contract
   
127
     
-
 
Prepaid and withholding taxes
   
6,297
     
5,702
 
Other temporary differences
   
543
     
563
 
                 
Deferred tax asset before valuation allowance
   
53,914
     
46,509
 
Valuation allowance
   
(49,928
)
   
(41,917
)
Deferred tax asset net of valuation allowance
   
3,986
     
4,592
 
                 
Deferred tax liability:
               
Intangible assets
   
3,284
     
3,354
 
Operating lease right-of-use assets
   
702
     
1,239
 
                 
Net deferred tax asset
 
$
-
   
$
-
 
 
As of December 31, 2023, the Company has provided a valuation allowance of approximately $50 million in respect of the Company’s deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of which are uncertain. As the Company has accumulated net operating losses for Israeli tax purposes as of December 31, 2023, in the amount of approximately $118,905, so it is more likely than not that sufficient taxable income will not be available for the tax losses to be utilized in the future. Therefore, a valuation allowance was recorded to reduce the deferred tax assets to nil.
 
Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence. Deferred taxes were not provided for undistributed earnings of the Company’s foreign subsidiaries. Currently, the Company does not intend to distribute any amounts of its undistributed earnings as dividends. Accordingly, no deferred income taxes have been provided in respect of these subsidiaries. If these earnings were distributed to Israel in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and foreign withholding taxes.
 
As of December 31, 2023, $ 5,220 of undistributed earnings held by the Company’s foreign subsidiaries are designated as indefinitely reinvested. If these earnings were re-patriated to Israel, they would be subject to income taxes and to an adjustment for foreign tax credits and foreign withholding taxes in the amount of $771. The Company did not recognize deferred taxes liabilities on undistributed earnings of its foreign subsidiaries, as the Company intends to indefinitely reinvest those earnings.
 
  h.
As of December 31, 2023 and 2022, the Company have an outstanding provision for uncertain tax position in the amount of $ 1,043 and $ 943, respectively.
 
The Company conducts business globally and, as a result, the Company or one or more of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities throughout the world, including such major jurisdictions as Israel, France, Spain, Japan and the United States. With a few exceptions, the Company is no longer subject to Israeli tax assessment through the year 2020 and the Spanish and U.S. subsidiaries have final tax assessments through 2018 and 2019, respectively.